THE US Food and Drug
Administration has successfully
prosecuted a case involving the
sale of unapproved chemotherapy
drugs, with an oncology practice
and its manager pleading guilty in
the case this week.
Hematology and Oncology Center
was investigated by the FDA after it
obtained “substantial amounts of
chemotherapy drugs” from Quality
Special Products, a foreign drug
distributor in Canada.
The medications were obtained
from Turkey, India and the EU,
following an earlier civil settlement
agreed to by the practice and its
managers in which they paid US$2
million “to resolve charges that
they violated the False Claims Act.”The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jun 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jun 14
IN ANTICIPATION of tonight’s Federal Budget, Kian Ghahramani (pictured), RSM’s National Director for Pharmacy, hopes for significant cost-of-living measures aimed at benefiting consumers and businesses alike.
NSW Minister for Health Ryan Park has announced that from 01 Jun, pharmacists across the state will be authorised permanently to treat uncomplicated urinary tract infections (UTIs), following the successful completion of a 12-month trial (PD breaking news).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.